Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-(3-Methyl-2-pyridinyl)piperazine → 2-{[4-(3-Methyl-2-pyridinyl)-1-piperazinyl]methyl}furo[3,2-b]pyridine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-(3-Methyl-2-pyridinyl)piperazine | HCID 2760057 | — |
| 반응물 | Sodium triacetoxyborohydride | HCID 5049666 | — |
| 생성물 | 2-{[4-(3-Methyl-2-pyridinyl)-1-piperazinyl]methyl}furo[3,2-b]pyridine | HCID 9861425 | — |
반응 단계
The product from Example 35B, 1-(3-methyl-2-pyridinyl)piperazine, and sodium triacetoxyborohydride were processed as described in Example 35C to provide the title compound. 1H NMR (CDCl3, 300 MHz) δ 2.68 (m, 4H), 3.29 (s, 3H), 3.58 (m, 4H), 3.79 (s, 2H), 6.41 (d, J=8.48 Hz, 1H), 6.49 (d, J=7.12 Hz, 1H), 6.85 (s, 1H), 7.18 (dd, J=4.75, 8.14 Hz, 1H), 7.36 (dd, J=7.12, 8.14 Hz, 1H), 7.73 (dd, J=1.02, 8.14 Hz, 1H), 8.51 (dd, J=1.36, 4.75 Hz, 1H); MS (DCI/NH3) m/z 309.2 (M+H)+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07470691B2 |
| 출처 데이터셋 | uspto-grants-2008_12 |
| ORD ID | ord-a7d711ac064c4134bc4bbff24d9d8cc8 |
| 출처 메모 | uspto-grants-2008_12 |